Robert J. Lake

Teacher, writer, editor, investor, stock analyst, (and part-time Uber driver!).
I believe time is the most valuable thing you can give someone.

[Robert J. Lake @Roblake29]

My latest analysis on @MadrigalPharma What an interesting company! This is my initial take on it. Thoughts welcome: https://t.co/WJqPAj6uEk

[Robert J. Lake @Roblake29]

Am I crazy for continuing to rate @InModeSolutions a strong buy? $INMD Read my thoughts here: https://t.co/NTUhHQIExK

[Robert J. Lake @Roblake29]

Time for a rating upgrade for @CintasCorp Love this company! Here is my analysis. Thoughts welcome: https://t.co/q2OYfrF80f

[Robert J. Lake @Roblake29]

My latest article on $CRSP @CRISPRTX Also my 101st for Seeking Alpha. Thanks to all my readers! Read why I am maintaining my buy rating, despite slow Casgevy roll-out. https://t.co/3R2fdanU0I

[Robert J. Lake @Roblake29]

Hot off the press! My latest analysis of @jobyaviation Read why I'm maintaining my buy rating here: https://t.co/d0daFdrGyy

[Robert J. Lake @Roblake29]

My latest. @NextpowerInc gets a buy rating, but watch out for AI/data center growth hype fueling sentiment shifts: https://t.co/EZE9Ghxf4E

[Robert J. Lake @Roblake29]

My latest stock analysis. Boston Scientific @bostonsci Read it here. Comments welcome: https://t.co/IPbhDusxKe

[Robert J. Lake @Roblake29]

SA Asks: What's the long-term outlook for solar stocks? https://t.co/m48bOHeS44

[Robert J. Lake @Roblake29]

Curious about Tempus AI @TempusAI ? Read my take on it here. I believe it could become a health technology powerhouse, advancing data-driven precision medicine into the new age: https://t.co/1BYB4EYxsc

[Robert J. Lake @Roblake29]

My latest analysis. An update on @boydgaming Sticking with my Hold rating: https://t.co/CA5SAkotYF

[Robert J. Lake @Roblake29]

An update on @RecursionPharma You can read my take, and buy, sell, hold recommendation here: https://t.co/wV5FCt1jHU

[Robert J. Lake @Roblake29]

Here's an update on my previous analysis of $mdt @Medtronic Read here: https://t.co/8KIn0xzQu7

[Robert J. Lake @Roblake29]

My latest analysis. This was an interesting one, a comparison of Idexx Labs and Zoetis. @IDEXX @Laboratories @IDEXXwater @Zoetis Thoughts welcome: https://t.co/4mLqlkPbXL

[Robert J. Lake @Roblake29]

My latest on @CareDx I am maintaining my "hold" rating, but consider this a buy under $18 a share: https://t.co/6bROHqjF6e

[Robert J. Lake @Roblake29]

My latest on @SolarEdgePV https://t.co/2NWJHbrcen

[Robert J. Lake @Roblake29]

@StockMarketNerd Brad, I think one of the most important skills to develop as an investor is the ability to determine who is worth listening to for advice/guidance/insight and who to avoid. Would you agree?

[Robert J. Lake @Roblake29]

Check in out, my latest analysis of Crispr Therapeutics. @CRISPRTX Read why I have retained a Strong Buy rating on the stock: https://t.co/KWOslEnmQV

[Robert J. Lake @Roblake29]

My latest write-up. This one is on $LENZ Lenz Therapeutics. After a bullish take in my initial coverage, their Q4 results have forced a bearish revaluation: https://t.co/QuDwSMQdVw

[Robert J. Lake @Roblake29]

My latest analysis of $ALGN @AlignTechInc https://t.co/JqY0m2HJTr

[Robert J. Lake @Roblake29]

My latest update on @Stellantis Read it here. I think it deserves an upgrade: https://t.co/KqwHhzg6DS